Menu Search
Equities

Bangkok Dusit Medical Services PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BDMS-R:SET

Bangkok Dusit Medical Services PCL

Actions
  • Price (THB)21.70
  • Today's Change-0.10 / -0.46%
  • Shares traded12.22m
  • 1 Year change-7.26%
  • Beta--
Data delayed at least 15 minutes, as of Feb 18 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Institutional shareholders

3.87%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 06 Feb 2026265.38m1.67%
BlackRock Advisors (UK) Ltd.as of 06 Feb 2026116.00m0.73%
Geode Capital Management LLCas of 12 Feb 202650.68m0.32%
Schroder Investment Management Ltd.as of 31 Dec 202540.84m0.26%
DWS Investments (UK) Ltd.as of 05 Feb 202632.03m0.20%
BlackRock Investment Management (UK) Ltd.as of 05 Feb 202625.24m0.16%
Sjunde AP-fondenas of 31 Dec 202523.39m0.15%
Northern Trust Investments, Inc.(Investment Management)as of 06 Feb 202621.94m0.14%
State Street Global Advisors Ltd.as of 05 Feb 202621.05m0.13%
JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 202519.07m0.12%
More ▼
Data from 30 Sep 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.